Based on previous studies, we conclude that the pathogenesis of PAH is closely associated with genetic mutations, such as bone morphogenetic protein receptor type 2 (BMPR2), and with cytosolic calcium and inflammation [3]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.